Highlights
NASDAQ: GERN       Geron Corp
Last Price Today's Change   Day's Range   Trading Volume
1.81   -0.02 (1.09%)  1.805 - 1.85  198,635

Overview

 
Avg Volume (4 weeks):2,812,375
4 Weeks Range:1.67 - 2.15
4 Weeks Price Volatility (%):
29.17%
52 Weeks Range:0.75 - 2.40
52 Weeks Price Volatility (%):
64.24%
Average Price Target: 1.75
Price Target Upside/Downside: -0.06

Headlines



No recent Headlines for this stock.


Business Background

Geron Corp is a clinical stage biopharmaceutical company. Its focus is the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Imelstat is expected to directly obstruct malignant-cell proliferation. The company has an exclusive collaboration and license agreement with Janssen Biotech to develop and commercialize imetelstat worldwide for oncology and other human therapeutic uses.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2206  3596  441  3145 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 AMD 80.355-1.875 
 ISIG 1.25+0.304 
 OAS 0.155-0.014 
 NIO 27.141+1.13 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 AAPL 116.569+1.518 
 XOG 0.271-0.062 
 SNAP 41.64+0.37